Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma

Nature Communications

Volumn 7, Issue , 2016, Pages

  Bagó, Juli R ^a   Alfonso Pecchio, Adolfo ^a   Okolie, Onyi ^a   Dumitru, Raluca ^b   Rinkenbaugh, Amanda ^b,c   Baldwin, Albert S ^c   Miller, C Ryan ^b,c   Magness, Scott T ^b   Hingtgen, Shawn D ^a,b,c  

^a University of North Carolina   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; CANCER; CELLS AND CELL COMPONENTS; GENE; INHIBITION; RODENT; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSDIFFERENTIATION; COCULTURE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; TIME LAPSE IMAGING; TUMOR XENOGRAFT; ANIMAL; ASTROCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CYTOLOGY; EXPERIMENTAL NEOPLASM; FIBROBLAST; INDUCED PLURIPOTENT STEM CELL; PHYSIOLOGY;

MURINAE;

ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; FIBROBLASTS; GLIOBLASTOMA; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; NEOPLASMS, EXPERIMENTAL; NEURAL STEM CELLS;

EID: 84957578076     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10593     Document Type: Article

References (43)

1. Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101-106 (2008).
2. Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317 (2007).
3. Robinton, D. A. & Daley, G. Q. The promise of induced pluripotent stem cells in research and therapy. Nature 481, 295-305 (2012).
4. Lujan, E. & Wernig, M. The many roads to Rome: induction of neural precursor cells from fibroblasts. Curr. Opin. Genet. Dev. 22, 517-522 (2012).
5. Kim, J. et al. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc. Natl Acad. Sci. USA 108, 7838-7843 (2011).
6. Lujan, E., Chanda, S., Ahlenius, H., Sudhof, T. C. & Wernig, M. Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc. Natl Acad. Sci. USA 109, 2527-2532 (2012).
7. Sheng, C. et al. Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors. Cell Res. 22, 208-218 (2012).
8. Thier, M. et al. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell 10, 473-479 (2012).
9. Ring, K. L. et al. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell 11, 100-109 (2012).
10. Han, D. W. et al. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell 10, 465-472 (2012).
11. Adamson, C. et al. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin. Investig. Drugs 18, 1061-1083 (2009).
12. Stupp, R. et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10, 459-466 (2009).
13. Hingtgen, S. et al. A first-generation multi-functional cytokine for simultaneous optical tracking and tumour therapy. PLoS ONE 7, e40234 (2012).
14. Hingtgen, S. et al. Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide. Mol. Cancer Ther. 7, 3575-3585 (2008).
15. Hingtgen, S. D., Kasmieh, R., van de Water, J., Weissleder, R. & Shah, K. A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. Stem Cells 28, 832-841 (2010).
16. Ahmed, A. U., Alexiades, N. G. & Lesniak, M. S. The use of neural stem cells in cancer gene therapy: predicting the path to the clinic. Curr. Opin. Mol. Ther. 12, 546-552 (2010).
17. Aboody, K., Capela, A., Niazi, N., Stern, J. H. & Temple, S. Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta stone. Neuron 70, 597-613 (2011).
18. Aboody, K. S. et al. Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies. Sci. Transl. Med. 5, 184ra159 (2013).
19. Ernst, N. et al. An improved, standardised protocol for the isolation, enrichment and targeted neural differentiation of Nestin + progenitors from adult human dermis. Exp. Dermatol. 19, 549-555 (2010).
20. Ehtesham, M. et al. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res. 62, 5657-5663 (2002).
21. Wakimoto, H. et al. Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res. 69, 3472-3481 (2009).
22. Hingtgen, S. D., Kasmieh, R., van de Water, J., Weissleder, R. & Shah, K. Determining multiple aspects of stem cell-based therapies using novel diagnostic and therapeutic multifunctional molecules. Stem Cells 28, 832-841 (2010).
23. Kauer, T. M., Figueiredo, J. L., Hingtgen, S. & Shah, K. Encapsulated therapeutic stem cells implanted in the tumour resection cavity induce cell death in gliomas. Nat. Neurosci. 15, 197-204 (2011).
24. Sasportas, L. S. et al. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc. Natl Acad. Sci. USA 106, 4822-4827 (2009).
25. Abdulghani, J. & El-Deiry, W. S. TRAIL receptor signaling and therapeutics. Expert Opin. Ther. Targets 14, 1091-1108 (2010).
26. Aboody, K. S., Najbauer, J. & Danks, M. K. Stem and progenitor cell-mediated tumour selective gene therapy. Gene Ther. 15, 739-752 (2008).
27. Ahmed, A. U. et al. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma. Mol. Pharm. 8, 1559-1572 (2011).
28. Young, J. S. et al. Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy. Expert Opin. Drug. Deliv. 11, 1733-1746 (2014).
29. Carney, B. J. & Shah, K. Migration and fate of therapeutic stem cells in different brain disease models. Neuroscience 197, 37-47 (2011).
30. Jurvansuu, J. et al. Transmembrane protein 18 enhances the tropism of neural stem cells for glioma cells. Cancer Res. 68, 4614-4622 (2008).
31. Magge, S. N. et al. Role of monocyte chemoattractant protein-1 (MCP-1/CCL2) in migration of neural progenitor cells toward glial tumours. J. Neurosci. Res. 87, 1547-1555 (2009).
32. Park, K. I. et al. Acute injury directs the migration, proliferation, and differentiation of solid organ stem cells: evidence from the effect of hypoxia-ischemia in the CNS on clonal 'reporter' neural stem cells. Exp. Neurol. 199, 156-178 (2006).
33. Zhang, S., Luo, X., Wan, F. & Lei, T. The roles of hypoxia-inducible factors in regulating neural stem cells migration to glioma stem cells and determinating their fates. Neurochem. Res. 37, 2659-2666 (2012).
34. Zhao, D. et al. Neural stem cell tropism to glioma: critical role of tumour hypoxia. Mol. Cancer Res. 6, 1819-1829 (2008).
35. Liu, G. H., Yi, F., Suzuki, K., Qu, J. & Izpisua Belmonte, J. C. Induced neural stem cells: a new tool for studying neural development and neurological disorders. Cell Res. 22, 1087-1091 (2012).
36. Schmid, R. S., Vitucci, M. & Miller, C. R. Genetically engineered mouse models of diffuse gliomas. Brain Res. Bull. 88, 72-79 (2012).
37. Zhou, Y. Y. & Zeng, F. Integration-free methods for generating induced pluripotent stem cells. Genomics Proteomics Bioinformatics 11, 284-287 (2013).
38. Adler, A. et al. Nonviral direct conversion of primary mouse embryonic fibroblasts to neuronal cells. Mol. Ther. 1, e32 (2012).
39. Kauer, T. M., Figueiredo, J. L., Hingtgen, S. & Shah, K. Encapsulated therapeutic stem cells implanted in the tumour resection cavity induce cell death in gliomas. Nat. Neurosci. 15, 197-204 (2012).
40. Chen, R. et al. A hierarchy of self-renewing tumour-initiating cell types in glioblastoma. Cancer Cell 17, 362-375 (2010).
41. Sena-Esteves, M., Tebbets, J. C., Steffens, S., Crombleholme, T. & Flake, A. W. Optimized large-scale production of high titer lentivirus vector pseudotypes. J. Virol. Methods 122, 131-139 (2004).
42. Hingtgen, S. et al. Real-time multi-modality imaging of glioblastoma tumour resection and recurrence. J. Neurooncol. 111, 153-161 (2013).
43. Heit, B. & Kubes, P. Measuring chemotaxis and chemokinesis: the under-agarose cell migration assay. Sci. STKE 2003, PL5 (2003).